EMA — authorised 1 February 2013
- Marketing authorisation holder: Sanofi-Aventis Groupe
- Status: approved
🇪🇺 Adlyxin in European Union
EMA authorised Adlyxin on 1 February 2013
Marketing authorisation
Adlyxin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Adlyxin approved in European Union?
Yes. EMA authorised it on 1 February 2013.
Who is the marketing authorisation holder for Adlyxin in European Union?
Sanofi-Aventis Groupe holds the EU marketing authorisation.